Michael Kishbauch

2011

In 2011, Michael Kishbauch earned a total compensation of $1.4M as Director, Former President and Chief Executive Officer Retired at Achillion Pharmaceuticals, a 24% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$270,810
Option Awards$694,388
Salary$450,000
Other$7,703
Total$1,422,901

Kishbauch received $694.4K in option awards, accounting for 49% of the total pay in 2011.

Kishbauch also received $270.8K in non-equity incentive plan, $450K in salary and $7.7K in other compensation.

Rankings

In 2011, Michael Kishbauch's compensation ranked 4,409th out of 10,747 executives tracked by ExecPay. In other words, Kishbauch earned more than 59.0% of executives.

ClassificationRankingPercentile
All
4,409
out of 10,747
59th
Division
Manufacturing
1,564
out of 3,960
61st
Major group
Chemicals And Allied Products
322
out of 1,038
69th
Industry group
Drugs
193
out of 786
75th
Industry
Pharmaceutical Preparations
151
out of 571
74th
Source: SEC filing on April 18, 2014.

Kishbauch's colleagues

We found five more compensation records of executives who worked with Michael Kishbauch at Achillion Pharmaceuticals in 2011.

2011

Elizabeth Olek

Achillion Pharmaceuticals

Chief Medical Officer

2011

Milind Deshpande

Achillion Pharmaceuticals

Chief Executive Officer

2011

Joseph Truitt

Achillion Pharmaceuticals

Executive Vice President and Chief Commercial Officer

2011

Gautam Shah

Achillion Pharmaceuticals

Executive Vice President and Chief Compliance Officer

2011

Mary Fenton

Achillion Pharmaceuticals

Chief Financial Officer

You may also like